Addressing lipid risk: a system-wide approach to implementation - PACE-CME

Addressing lipid risk a systemwide approach to implementation

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Icosapent ethyl in post-CABG patients with diabetes
Icosapent ethyl in post-CABG patients with diabetes
Hyperlipidemia
Icosapent ethyl in post-CABG patients with diabetes
- Subodh Verma, MD, PhD
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
- C. David Mazer, MD
Predicting 30-year CV outcomes in women
Predicting 30-year CV outcomes in women
ESC Congress 2024
Predicting 30-year CV outcomes in women
- Paul Ridker, MD
Intensive and early lowering of atherogenic lipids after MI
Intensive and early lowering of atherogenic lipids after MI
ESC Congress 2024
Intensive and early lowering of atherogenic lipids after MI
- Jessica Schubert, MD